Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306173767> ?p ?o ?g. }
- W4306173767 endingPage "257" @default.
- W4306173767 startingPage "250" @default.
- W4306173767 abstract "We evaluated the activity of ceftolozane/tazobactam (C/T), and comparators against clinical Pseudomonas aeruginosa isolates collected for the global Study for Monitoring Antimicrobial Resistance Trends (SMART) surveillance program in ten countries in the Middle East and Africa to augment scarce standardized surveillance data in this region.Minimum inhibitory concentrations (MICs) were determined using Clinical and Laboratory Standards Institute broth microdilution and interpreted with European Committee on Antimicrobial Susceptibility Testing breakpoints. P. aeruginosa isolates testing with C/T MIC >4 mg/l or imipenem MIC >2 mg/l were screened for β-lactamase genes.C/T was active against 91.4% and 87.0% of P. aeruginosa isolates from the Middle East and Africa, respectively (14-21 and 7-16 percentage points higher than most β-lactam comparators, respectively). Considerable variation in susceptibility was seen across countries, which largely correlated with the observed prevalence of carbapenemases and/or extended-spectrum β-lactamases. Differences across countries were smaller for C/T than for the β-lactam comparators, ranging from 81% C/T-susceptible among isolates from Jordan to 95% for Qatar. Among subsets resistant to meropenem, ceftazidime, or piperacillin/tazobactam, C/T maintained activity against 51-73% of isolates from the Middle East and against 27-54% from Africa (where metallo-β-lactamase and GES carbapenemase rates were higher).Given the desirability of β-lactam use among clinicians, C/T represents an important option in the treatment of infections caused by P. aeruginosa." @default.
- W4306173767 created "2022-10-14" @default.
- W4306173767 creator A5010169434 @default.
- W4306173767 creator A5017159626 @default.
- W4306173767 creator A5035614223 @default.
- W4306173767 creator A5037643218 @default.
- W4306173767 creator A5038009031 @default.
- W4306173767 creator A5042149117 @default.
- W4306173767 creator A5048040439 @default.
- W4306173767 creator A5089366807 @default.
- W4306173767 date "2022-12-01" @default.
- W4306173767 modified "2023-09-25" @default.
- W4306173767 title "Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020" @default.
- W4306173767 cites W1618166169 @default.
- W4306173767 cites W1993037671 @default.
- W4306173767 cites W2024648459 @default.
- W4306173767 cites W2033235589 @default.
- W4306173767 cites W2075287054 @default.
- W4306173767 cites W2098310975 @default.
- W4306173767 cites W2104664066 @default.
- W4306173767 cites W2146370566 @default.
- W4306173767 cites W2149088130 @default.
- W4306173767 cites W2152620389 @default.
- W4306173767 cites W2164611092 @default.
- W4306173767 cites W2190529098 @default.
- W4306173767 cites W2219569661 @default.
- W4306173767 cites W2279161813 @default.
- W4306173767 cites W2408072278 @default.
- W4306173767 cites W2516362618 @default.
- W4306173767 cites W2587924352 @default.
- W4306173767 cites W2615674137 @default.
- W4306173767 cites W2622307274 @default.
- W4306173767 cites W2623315557 @default.
- W4306173767 cites W2790746335 @default.
- W4306173767 cites W2802825811 @default.
- W4306173767 cites W2804230504 @default.
- W4306173767 cites W2887531173 @default.
- W4306173767 cites W2889310170 @default.
- W4306173767 cites W2890567078 @default.
- W4306173767 cites W2895115582 @default.
- W4306173767 cites W2896307216 @default.
- W4306173767 cites W2905159697 @default.
- W4306173767 cites W2921820474 @default.
- W4306173767 cites W2922274176 @default.
- W4306173767 cites W2938723873 @default.
- W4306173767 cites W2942583672 @default.
- W4306173767 cites W2946373612 @default.
- W4306173767 cites W2969690451 @default.
- W4306173767 cites W2972310482 @default.
- W4306173767 cites W2975667851 @default.
- W4306173767 cites W2980596798 @default.
- W4306173767 cites W2990221023 @default.
- W4306173767 cites W3003935215 @default.
- W4306173767 cites W3005560251 @default.
- W4306173767 cites W3042826286 @default.
- W4306173767 cites W3048398081 @default.
- W4306173767 cites W3126580301 @default.
- W4306173767 cites W3132704259 @default.
- W4306173767 cites W3134427103 @default.
- W4306173767 cites W3137185875 @default.
- W4306173767 cites W3155949245 @default.
- W4306173767 cites W3165125948 @default.
- W4306173767 cites W4200319621 @default.
- W4306173767 doi "https://doi.org/10.1016/j.ijid.2022.10.014" @default.
- W4306173767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36244599" @default.
- W4306173767 hasPublicationYear "2022" @default.
- W4306173767 type Work @default.
- W4306173767 citedByCount "1" @default.
- W4306173767 countsByYear W43061737672023 @default.
- W4306173767 crossrefType "journal-article" @default.
- W4306173767 hasAuthorship W4306173767A5010169434 @default.
- W4306173767 hasAuthorship W4306173767A5017159626 @default.
- W4306173767 hasAuthorship W4306173767A5035614223 @default.
- W4306173767 hasAuthorship W4306173767A5037643218 @default.
- W4306173767 hasAuthorship W4306173767A5038009031 @default.
- W4306173767 hasAuthorship W4306173767A5042149117 @default.
- W4306173767 hasAuthorship W4306173767A5048040439 @default.
- W4306173767 hasAuthorship W4306173767A5089366807 @default.
- W4306173767 hasBestOaLocation W43061737671 @default.
- W4306173767 hasConcept C176947019 @default.
- W4306173767 hasConcept C2775933652 @default.
- W4306173767 hasConcept C2776968632 @default.
- W4306173767 hasConcept C2777637488 @default.
- W4306173767 hasConcept C2777858937 @default.
- W4306173767 hasConcept C2778193466 @default.
- W4306173767 hasConcept C2778266534 @default.
- W4306173767 hasConcept C2779375183 @default.
- W4306173767 hasConcept C2779631663 @default.
- W4306173767 hasConcept C2780950330 @default.
- W4306173767 hasConcept C42972112 @default.
- W4306173767 hasConcept C4937899 @default.
- W4306173767 hasConcept C501593827 @default.
- W4306173767 hasConcept C523546767 @default.
- W4306173767 hasConcept C54355233 @default.
- W4306173767 hasConcept C71924100 @default.
- W4306173767 hasConcept C86803240 @default.
- W4306173767 hasConcept C89423630 @default.
- W4306173767 hasConcept C94665300 @default.